FEMSelect Ltd. (formerly POP Medical Solutions Ltd.)
FEMSelect (formerly POP Medical) developed EnPlace, a minimally invasive, mesh-free approach to prolapse repair. Standard of care is complex & invasive surgery.
FEMSelect developed and received FDA clearance in 2016 for a minimally-invasive, meshless, minimally-invasive approach to prolapse repair procedures. The EnPlace approach is an easier and shorter procedure with fewer complications than current treatments. FEMSelect is seeking funding to bridge to a Round B which will enable the company to build a commercial organization in the US and launch the product in 5 regions.